Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies

Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies

US Patent 9169255 · Granted Oct 27, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthesis of coelenterazine2024
Compositions and methods for the treatment of “plaques and tangles” in humans an2022
Compositions and methods for the treatment of plaques and tangles in humans and 2022
Compositions and methods for the treatment of plaques and tangles in humans and 2022
Compositions and methods for the treatment of plaques and tangles in humans and 2022
Synthesis of coelenterazine2021
GPR119 agonist compounds2021
Compounds as GPR119 agonists2021
GPR119 agonist compounds2020
Compounds as GPR119 agonists2020
Compositions and methods for the treatment of plaques and tangles in humans and 2019
Compositions and methods for the treatment of plaques and tangles in humans and 2019